SuperworthAnavex Life Sciences shares outstanding AVXL
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 92.9M
- On a year earlier
- +8.8%
- more shares
Anavex Life Sciences had 92.9M diluted shares outstanding on average in Q3 FY26, the quarter to Jun 30, 2026.
That is 8.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 85.9M | +1% |
| FY2024 | 84.8M | +3% |
| FY2023 | 82M | +35% |
| FY2020 | 60.6M | +15% |
| FY2019 | 52.5M | +15% |
| FY2018 | 45.5M | +8% |
| FY2017 | 42.3M | +18% |
| FY2016 | 35.7M | +28% |
| FY2015 | 27.9M | +153% |
| FY2014 | 11.1M | +20% |
| FY2013 | 9.2M | +22% |
| FY2012 | 7.6M | +16% |
| FY2011 | 6.5M | +15% |
| FY2010 | 5.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 92.9M | +9% | |
| Q2 FY26 | 92.7M | +9% | |
| Q1 FY26 | 89M | +5% | |
| Q4 FY25 | 85.9M | +1% | |
| Q3 FY25 | 85.4M | +1% | |
| Q2 FY25 | 85.1M | +3% | |
| Q1 FY25 | 84.8M | +3% | |
| Q4 FY24 | 84.8M | +3% | |
| Q3 FY24 | 84.5M | +5% | |
| Q2 FY24 | 82.5M | +5% | |
| Q1 FY24 | 82.1M | +5% | |
| Q4 FY23 | 82M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Anavex Life Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.